Singapur - inglise - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - azilsartan medoxomil potassium 42.68mg eqv azilsartan medoxomil - tablet - 40mg

Singapur - inglise - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - azilsartan medoxomil potassium 85.36mg eqv azilsartan medoxomil - tablet - 80mg

Kanada - inglise - Health Canada

teva canada limited - rasagiline (rasagiline mesylate) - tablet - 0.5mg - rasagiline (rasagiline mesylate) 0.5mg - monoamine oxidase b inhibitors

Kanada - inglise - Health Canada

teva canada limited - rasagiline (rasagiline mesylate) - tablet - 1mg - rasagiline (rasagiline mesylate) 1mg - monoamine oxidase b inhibitors

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

azurity pharmaceuticals, inc. (formerly arbor pharmaceuticals) - azilsartan kamedoxomil (unii: wec6i2k1fc) (azilsartan - unii:f9nux55p23), chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - azilsartan medoxomil 40 mg - edarbyclor is indicated for the treatment of hypertension, to lower blood pressure. edarbyclor may be used in patients whose blood pressure is not adequately controlled on monotherapy. edarbyclor may be used as initial therapy if a patient is likely to need multiple drugs to achieve blood pressure goals. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including thiazide-like diuretics such as chlorthalidone and arbs such as azilsartan medoxomil. there are no controlled trials demonstrating risk reduction with edarbyclor. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achi

Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - azilsartan - faintly yellowish red tablet, diameter: 5.6 mm, thickness: 2.8 mm

Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

daiichi sankyo espha co., ltd. - azilsartan - faint yellowish red tablet, diameter: 5.6 mm, thickness: 2.8 mm

Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - azilsartan - faintly red tablet, diameter: 7.1 mm, thickness: 3.5 mm

Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

daiichi sankyo espha co., ltd. - azilsartan - faint red tablet, diameter: 7.1 mm, thickness: 3.5 mm

Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - azilsartan - yellow tablet, diameter: 8.1 mm, thickness: 3.6 mm